REDENTI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.812
EU - Europa 1.441
AS - Asia 899
SA - Sud America 109
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 4.326
Nazione #
US - Stati Uniti d'America 1.771
PL - Polonia 353
IT - Italia 319
SG - Singapore 284
SE - Svezia 207
CN - Cina 201
DE - Germania 106
BR - Brasile 87
FR - Francia 76
GB - Regno Unito 76
NL - Olanda 70
IN - India 63
VN - Vietnam 63
HK - Hong Kong 61
BD - Bangladesh 55
KR - Corea 49
UA - Ucraina 48
FI - Finlandia 46
RU - Federazione Russa 44
TR - Turchia 36
CA - Canada 26
EG - Egitto 23
BG - Bulgaria 20
IE - Irlanda 17
PK - Pakistan 15
CZ - Repubblica Ceca 14
JP - Giappone 13
BE - Belgio 10
AR - Argentina 8
AT - Austria 8
IQ - Iraq 8
ID - Indonesia 7
CO - Colombia 6
ES - Italia 6
MA - Marocco 6
PH - Filippine 5
TH - Thailandia 5
TW - Taiwan 5
UZ - Uzbekistan 5
DZ - Algeria 4
EU - Europa 4
IR - Iran 4
KE - Kenya 4
MX - Messico 4
SA - Arabia Saudita 4
AU - Australia 3
BB - Barbados 3
CI - Costa d'Avorio 3
EC - Ecuador 3
ET - Etiopia 3
LT - Lituania 3
TT - Trinidad e Tobago 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CH - Svizzera 2
EE - Estonia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PE - Perù 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CL - Cile 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MG - Madagascar 1
MN - Mongolia 1
MV - Maldive 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TG - Togo 1
VE - Venezuela 1
ZM - Zambia 1
Totale 4.326
Città #
Dallas 349
Warsaw 338
Singapore 171
Ashburn 151
Fairfield 103
Houston 101
Chandler 99
Trieste 96
Woodbridge 92
Ann Arbor 87
Hefei 78
San Jose 74
Cambridge 59
Hong Kong 55
Wilmington 55
Seoul 47
Seattle 46
Munich 45
Beijing 44
Jacksonville 44
Amsterdam 32
The Dalles 27
Columbus 25
Princeton 25
Boardman 23
Cairo 22
Los Angeles 22
Milan 22
Sofia 20
Izmir 18
London 18
Dublin 17
Helsinki 16
Mestre 16
Buffalo 15
Chicago 15
Frankfurt am Main 15
Istanbul 15
New York 15
Santa Clara 15
Turku 14
Hanoi 13
Ho Chi Minh City 13
North Bergen 13
Brno 12
Rome 12
Chennai 11
Düsseldorf 11
Lauterbourg 11
Moscow 11
Tokyo 11
Zgierz 11
Shanghai 10
Guangzhou 9
Toronto 8
Udine 8
Dhaka 7
Redwood City 7
Verona 7
Council Bluffs 6
Falls Church 6
Indore 6
Kanpur 6
Nanchang 6
Nashville 6
Phoenix 6
Sacile 6
São Paulo 6
Torre Del Greco 6
West Jordan 6
Brooklyn 5
Brussels 5
Orem 5
Poplar 5
San Francisco 5
Spinea 5
Tashkent 5
Vienna 5
Bremen 4
Cagliari 4
Casablanca 4
Dong Ket 4
Lahore 4
Manchester 4
Nairobi 4
New Delhi 4
Padova 4
Philadelphia 4
Pittsburgh 4
Redondo Beach 4
Urbino 4
Abidjan 3
Atlanta 3
Boston 3
Bridgetown 3
Campinas 3
Citta 3
Codroipo 3
Dearborn 3
Delhi 3
Totale 2.911
Nome #
[1,2,4]triazolo[1,5-c]pyrimidines as A(3) adenosine receptor antagonists 660
DESIGN, SYNTHESIS AND CHARACTERIZATION OF GSK-3β AND CK-1δ INHIBITORS 521
The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives 441
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition 397
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists 355
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors 292
Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5- c ]pyrimidines to explore the antagonist profiling on adenosine receptors: A preliminary structure-activity relationship study 286
null 245
Mixed-reversible and covalent kinase inhibition as a possible new strategy to treat neuro-inflammatory/degenerative diseases 243
N8-Isopentyl and N8-Phenylethyl Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Derivatives as Adenosine Receptor Antagonists 242
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems 226
Conjugable A3 Adenosine Receptor Antagonists: Probing the 5 Position of the Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Scaffold. 165
CVT 6975-like Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Derivatives: an Attempt towards A2B Adenosine Receptor Affinity. 164
null 97
null 89
Totale 4.423
Categoria #
all - tutte 9.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/2022266 13 25 17 73 11 10 7 8 31 30 5 36
2022/2023295 29 44 21 51 26 51 0 21 36 7 9 0
2023/2024255 10 16 19 13 18 29 62 44 3 14 12 15
2024/2025585 32 25 63 52 42 34 35 24 61 85 47 85
2025/20261.465 171 168 347 92 74 68 140 35 105 133 57 75
Totale 4.423